<DOC>
	<DOCNO>NCT02909621</DOCNO>
	<brief_summary>This study prospective , randomize , double-blind , placebo-controlled 3 parallel-groups multicenter trial patient suffer knee OA ( osteoarthrosis ) . A first exploratory non comparative study ( TILFLEXY002 , NCT01909037 , Henrotin et al. , 2014 BMC Complementary Alternative Medicine ) evaluate efficacy FLEXOFYTOL® dose 2x3 caps/day , 3-month period , 22 patient suffer knee OA , serum level cartilage-specific inflammatory biomarkers , evaluation pain global patient assessment disease activity . This study demonstrate statistically significant decrease sColl2-1 cartilage specific biomarker , early decrease ultrasensitive C-reactive protein ( CRP ) , improvement global assessment disease patient well good tolerance compliance treatment . Results exploratory study encourage justify setup randomize , placebo-controlled double blind dose-ranging trial .</brief_summary>
	<brief_title>Evaluation FLEXOFYTOL® Versus PLACEBO</brief_title>
	<detailed_description>150 patient suffer symptomatic knee OA randomize 3 parallel group ( 50 patient per group ) . Each patient enrol study 6 month include 4 visit : Inclusion visit ( T0 ) , follow-up visit 1 month ( T1 ) , 3 month ( T3 ) 6 month ( T6 ) . A . Primary objective - Evaluate efficacy two different dosage FLEXOFYTOL® versus PLACEBO arthritis relate biomarker coll2-1 patient assessment disease activity patient suffer knee OA 3 month treatment B . Secondary objectives - Evaluate efficacy two different dosage FLEXOFYTOL® versus PLACEBO arthritis-related inflammatory biomarkers . - Evaluate efficacy two different dosage FL EXOFYTOL® versus PLACEBO pain function . - Evaluate tolerance , compliance patient ' satisfaction . - Evaluate use rescue treatment i.e . Paracetamol oral non-steroidal antiinflammatory drug ( NSAIDs ) study .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Turmeric extract</mesh_term>
	<criteria>Male female age 45 80 Artialis ( study coordinator ) Tilman ( Sponsor ) 's employee Participation therapeutic clinical trial last 3 month Under guardianship judicial protection</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>OsteoArthritis ; FLEXOFYTOL® ; Curcuma ; biomarkers</keyword>
</DOC>